Table 3.
Examples of porcine vaccines based on adenovirus vectors.
| Target pathogen | Target antigen | Reference |
|---|---|---|
| General overview | General overview | Porcine adenovirus type 3: [35] |
| Vector only | Vector development | Porcine adenovirus type 3: [195] |
| CSFV | gp55 (E2) glycoprotein | Porcine adenovirus type 3: [196] |
| CSFV | gp55 (E2) glycoprotein | Porcine adenovirus type 3: [197] |
| FMDV | VP1 | Canine adenovirus type 2: [198] |
| FMDV | P1 and protease | Human adenovirus type 5: [36], [199] |
| FMDV | P1 and protease/IFN-α | Human adenovirus type 5: [40] |
| Mycoplasma hyopneumoniae | P97 adhesin | Human adenovirus type 5: [200] |
| PCV2 | Capsid (ORF2) protein | Human adenovirus type 5: [201] |
| PCV2 | Capsid (ORF2) protein | Human adenovirus type 5: [202] |
| PRRSV | GP3 envelope protein | Human adenovirus type 5: [203] |
| PRRSV | GP5 and M proteins | Human adenovirus type 5: [204] |
| Porcine respiratory corona virus | Spike glycoprotein | Human adenovirus type 5: [205] |
| PRV | gD glycoprotein | Porcine adenovirus type 3: [206] |
| PRV | gD glycoprotein | Human adenovirus type 5: [207] |
| Swine influenza virus | Haemagglutinin | Human adenovirus type 5: [208] |
| Swine influenza virus | Haemagglutinin | Human adenovirus type 5: [209] |
| Swine influenza virus | Haemagglutinin | Human adenovirus type 5: [210] |
| TGEV | Spike glycoprotein | Human adenovirus type 5: [39] |